Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Syndrome

Recruiting Observational Study
Acute Respiratory Distress Syndrome
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
0 – 21
Sex
Any
Study type
Observational
Participants needed
1,260 (estimated)
Sponsor
Children's Hospital Los Angeles · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this observational study is to determine whether a marker of dead space (the end-tidal to alveolar dead space fraction \[AVDSf\]) is more strongly associated with mortality risk than markers of oxygenation abnormality (oxygenation index) and to determine whether dead space (AVDSf) is an important marker of heterogeneity in the inhaled nitric oxide (iNO) treatment effect for children wi…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age \>37 weeks corrected gestational age to 21 years, including adults lacking the capacity to consent. * Within 72 hours of the start of invasive mechanical ventilation and meet the criteria for pediatric ARDS (new infiltrate on chest imaging and a known ARDS risk factor with…
Contacts

Jeni Kwok

3233617939

dinostudy@chla.usc.edu

CONTACT

Anoopindar Bhalla, MD

3233617939

abhalla@chla.usc.edu

CONTACT